LYPD3

LYPD3 Molekülinformation

Englischer Name	Ly6/PLAUR domain-containing protein 3	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	1	Target-Alias	C4.4A，GPI-Anchored Metastasis-Associated Protein Homolog，2310061G07Rik，GPI-Anchored Metastasis-Associated Protein C4.4A Homolog，MIG-C4，UNQ491/PRO1007，Ly6/PLAUR domain-containing protein 3，LYPD3，Matrigel-Induced Gene C4 Protein，LY6/PLAUR Domain Containing 3
Höchste Forschungs- und Entwicklungsphase	Phase 1 Clinical

Englischer Name	Ly6/PLAUR domain-containing protein 3
Target-Alias	C4.4A，GPI-Anchored Metastasis-Associated Protein Homolog，2310061G07Rik，GPI-Anchored Metastasis-Associated Protein C4.4A Homolog，MIG-C4，UNQ491/PRO1007，Ly6/PLAUR domain-containing protein 3，LYPD3，Matrigel-Induced Gene C4 Protein，LY6/PLAUR Domain Containing 3
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	1
Höchste Forschungs- und Entwicklungsphase	Phase 1 Clinical

LYPD3 Produktliste

Attribut
Protein (1)
Produktbibliothek
Online (1)
Spezies
Human (1)
Etikett
His Tag (1)
Marker
Unconjugated (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Proteinstruktur	Reinheit	Eigenschaften	Vorbestellen/Bestellen
LY3-H52H5	Human	HEK293	Human LYPD3 / C4.4A Protein, His Tag				In den Warenkorb legen

Gesamtmenge1

LYPD3 Molekülhintergrund

Ly6/PLAUR domain-containing protein 3 (LYPD3) is also known as MIG-C4 ,C4.4A, GPI-anchored metastasis-associated protein C4.4A homolog and Matrigel-induced gene C4 protein,which is a cell membrane protein containing two UPAR/Ly6 domains. LYPD3 is expressed in placenta, skin and urothelium. LYPD3 is found in the majority of primary and metastatic transitional cell carcinomas (TCCs) and as well in breast cancer tissues, but not in adjacent normal tissues. LYPD3 play a role in supporting cell migration and it is not only probably involved in urothelial cell-matrix interactions, but also in tumor progression.